Human cytomegalovirus latency and reactivation - A delicate balance between the virus and its host's immune system

Intervirology

Volumn 42, Issue 5-6, 1999, Pages 314-321

  Söderberg Nauclér, Cecilia ^a   Nelson, Jay A ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Allogeneic stimulation; Cytomegalovirus; Latency; Macrophages; Reactivation

Indexed keywords

ANTIGEN RECOGNITION; CONFERENCE PAPER; HOST RESISTANCE; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE DEFICIENCY; IMMUNE SYSTEM; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS LATENCY; VIRUS REACTIVATION;

CYTOMEGALOVIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

EID: 0342680021     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053966     Document Type: Conference Paper

References (81)

1. Britt WJ, Alford CA: Cytomegalovirus; in Fields BN, Knipe DM, Howley PM (eds): Fields Virology. Philadelphia, Lippincott-Raven 1996, pp 2493-2523.
2. Onorato IM, Morens DM, Martone WJ, Stansfield SK: Epidemiology of cytomegaloviral infections: Recommendations for prevention and control. Rev Infect Dis 1985;7:479-497.
3. Minamishima I, Ueda K, Minematsu T, Minamishima Y, Umemoto M, Take H, Kuraya K: Role of breast milk in acquisition of cytomegalovirus infection. Microbiol Immunol 1994;38:549-552.
4. Grillner L, Strangert K: Restriction endonuclease analysis of cytomegalovirus DNA from strains isolated in day care centers. Pediatr Infect Dis 1986;5:184-187.
5. Hersman J, Meyers JD, Thomas ED, Buckner CD, Clift R: The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med 1982;96:149-152.
6. Bowden RA: Transfusion-transmitted cytomegalovirus infection. Hematol Oncol Clin N Am 1995;9:155-166.
7. Tegtmeier GE: Posttransfusion cytomegalovirus infections. Arch Pathol Lab Med 1989;113: 236-245.
8. Smiley ML, Wlodaver CG, Grossman RA, Barker CF, Perloff LJ, Tustin NB, Starr SE, Plotkin SA, Friedman HM: The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation. Transplantation 1985;40:157-161.
9. Demmler GJ: Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 1991;13:315-329.
10. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Wallon PD, Veren DA, Page F, Alford CA: Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 1986;256:1904-1908.
11. Yow MD, Demmler GJ: Congenital cytomegalovirus disease - 20 years is long enough. N Engl J Med 1992;326:702-703.
12. Ljungman P, Niederwieser D, Pepe MS, Longton G, Storb R, Meyers JD: Cytomegalovirus infection after marrow transplantation for aplastic anemia. Bone Marrow Transplant 1990;6:295-300.
13. Wingard JR: Viral infections in leukemia and bone marrow transplant patients. Leuk Lymphoma 1993;2:115-125.
14. Hicks T, Fowler K, Richardson M, Dahle A, Adams L, Pass R: Congenital cytomegalovirus infection and neonatal auditory screening. J Pediatrics 1993;123:779-782.
15. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE: Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994;265:391-394.
16. Torok-Storb B, Simmons P, Khaira D, Stachel D, Myerson D: Cytomegalovirus and marrow function. Ann Hematol 1992;64:4128-4131.
17. Söderberg C, Larsson S, Rozell BL, Sumitran-Karuppan S, Ljungman P, Möller E: Cytomegalovirus-induced CD13-specific autoimmunity - A possible cause of chronic graft-vs-host disease. Transplantation 1996;61:600-609.
18. Lönnqvist B, Ringden O, Wahren B, Gahrton G, Lundgren G: Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease. Transplantation 1984;38: 465-468.
19. Grattan MT, Moreno-Cabral CE, Starnes VA, Over PE, Stinson EB, Shumway NE: Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989;24:3561-3566.
20. Söderberg-Nauclér C, Fish KN, Nelson JA: Cytomegalovirus; in Chen SY, Rafi A (eds): Persistent Viral Infections. Chichester, Wiley 1999.
21. Sinzger C, Plachter B, Stenglein S, Jahn G: Immunohistochemical detection of viral antigens in smooth muscle, stromal, and epithelial cells from acute human cytomegalovirus gastritis. J Infect Dis 1993;167:1427-1432.
22. Sinzger C, Grefte A, Plachter B, Gouw AS, The TH, Jahn G: Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 1995;76:741-750.
23. Sinzger C, Muntefering H, Loning T, Stoss H, Plachter B, Jahn G: Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining. Virchows Archiv A Pathol Anat Histopathol 1993; 423:249-256.
24. Myerson D, Hackman RC, Nelson JA, Ward DC, McDougall JK: Widespread presence of histologically occult cytomegalovirus. Hum Pathol 1984;15:430-439.
25. Friedman HM, Macarak RR, MacGregor J, Kefalides NA: Virus infection of endothelial cells. J Infect Dis 1981;2:266-273.
26. Smiley ML, Mar EC, Huang ES: Cytomegalovirus infection and viral induced transformation of human endothelial cells. J Infect Dis 1988;2: 213-226.
27. Waldman WJ, Adams PW, Orosz CG, Sedmak DD: T lymphocyte activation by cytomegalovirus-infected, allogeneic cultured human endothelial cells. Transplantation 1992;54:887-896.
28. Turner RR, Beckstead JH, Warnke RA, Wood GS: Endothelial cell phenotypic diversity. In situ demonstration of immunologic and enzymatic heterogeneity that correlates with specific morphologic subtypes. Am J Clin Pathol 1987;5:569-575.
29. Fish KN, Söderberg-Nauclér C, Mills L, Stenglein S, Nlson JA: HCMV persistently infects aortic endothelial cells. J Virol 1998;7:5661-5668.
30. Melnick JL, Adam E, DeBakey ME: Cytomegalovirus and atherosclerosis. Bioessays 1995;17: 899-903.
31. Bruning JH, Persoons MCJ, Lemström KB, Staals FS, De Clereq E, Bruggeman CA: Enhancement of transplantation associated atherosclerosis by CMV, which can be prevented by antiviral therapy in the form of HPMPC. Transplant Int 1994;7:365-370.
32. Lemström K, Persoons M, Bruggeman C, Ustinov J, Lautenschlager I, Hayry P: Cytomegalovirus infection enhances allograft arteriosclerosis in the rat. Transplant Proc 1993;25:1406-1407.
33. Meyers JD: Prevention and treatment of cytomegalovirus infection. Annu Rev Med 1991; 42:179-187.
34. Chou SW: Acquisition of donor strains of cytomegalovirus by renal-transplant recipients. N Engl J Med 1986;314:1418-1423.
35. Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH: Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 1991;72:2059-2064.
36. Ibanez CE, Schrier R, Ghazal P, Wiley C, Nelson JA: Human cytomegalovirus productively infects primary differentiated macrophages. J Virol 1991;65:6581-6588.
37. Taylor-Wiedeman J, Sissons P, Sinclair J: Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol 1994; 68:1597-1604.
38. Rice GP, Schrier RD, Oldstone MB: Cytomegalovirus infects human lymphocytes and monocytes: Virus expression is restricted to immediate-early gene products. Proc Natl Acad USA 1984;81:6134-6138.
39. Sinzger C, Plachter B, Grefte A, The TH, Jahn G: Tissue macrophages are infected by human cytomegalovirus in vivo. J Infect Dis 1996;173: 240-245.
40. Gnann J Jr, Ahlmcn J, Svalander C, Olding L, Oldstone MB, Nelson JA: Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus. Am J Pathol 1988;132:239-248.
41. Gendelman HE, Baca LM, Kubrak CA, Genis P, Burrous S, Friedman RM, Jacobs D, Meltzer MS: Induction of IFN-alpha in peripheral blood mononuclear cells by HIV-infected monocytes. Restricted antiviral activity of the HIV-induced IFN. J Immunol 1992;148:422-429.
42. Kornbluth RS, Oh PS, Munis JR, Cleveland PH, Richman DD: The role of interferons in the control of HIV replication in macrophages. Clin Immunol Immunopathol 1990;54:200-219.
43. Söderberg-Nauclér C, Fish KN, Nelson JA: Interferon-γ and tumour necrosis factor-α specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J Clin Invest 1997;100:1-10.
44. Humbert M, Roux-Lombard P, Cerrina J, Magnan A, Simonneau G, Dartevelle P, Galanaud P, Dayer Jm, Emilie D: Soluble TNF receptors (TNF-sR55 and TNF-sR75) in lung allograft recipients displaying cytomegalovirus pneumonitis. Am J Resp Crit Care Med 1994; 149:1681-1685.
45. Fietze E, Prosch S, Reinke P, Stein J, Docke Wd, Staffa G, Loning S, Devaux S, Emmrich F, von Baehr R, et al: Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor. Transplantation 1994;58:675-680.
46. Tilg H, Vogel W, Aulitzky We, Herold M, Konigsrainer A, Margreiter R, Huber C: Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantation. Transplantation 1990;49:1074-1080.
47. Tilg H, Vogel W, Herold M, Aulitzky We, Huber C: Cachexia and tumour necrosis factor-alpha in cytomegalovirus infection. J Clin Pathol 1991;44:519-520.
48. Smith PD, Saini SS, Raffeld M, Manischewitz JF, Wahl SM: Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages. J Clin Invest 1992;90:1642-1648.
49. Stein J, Volk HD, Liebenthal C, Kruger DH, Prosch S: Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J Gen Virol 1993; 74:2333-2338.
50. Prösch S, Staak K, Stein J, Liebenthal C, Stamminger T, Volk KDH: Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNF-a is mediated via induction of NF-kB. Virology 1995;208:197-206.
51. Söderberg-Nauclér C, Fish KN, Nelson JA: Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997;3:119-126.
52. Söderberg-Nauclér C, Fish KN, Smith P, Allan.-Yorke J, Nelson JA: IFN-gamma dependent reactivation of latent HCMV in macrophages, submitted.
53. Minton EJ, Tysoe C, Sinclair JH, Sissons JG: Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J Virol 1994;68:4017-4021.
54. Maciejewski JP, Bruening EE, Donahue RE, Mocarski ES, Young NS, St Jeor SC: Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 1992;80:170-178.
55. Movassagh M, Gozlan J, Senechal B, Baillou C, Petit JC, Lemoine FM: Direct infection of CD34+ progenitor cells by human cytomegalovirus: Evidence for inhibition of hematopoiesis and viral replication. Blood 1996;88:1277-1283.
56. Sindre H, Tjoonnfjord GE, Rollag H, Ranneberg-Nilsen T, Veiby OP, Beck S, Degre M, Hestdal K: Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells. Blood 1996;88:4526-4533.
57. Mendelson M, Monard S, Sissons P, Sinclair J: Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol 1996;77:3099-3102.
58. von Laer D, Meyer-Koenig U, Serr A, Finke J, Kanz L, Fauser Aa, Neumann-Haefelin D, Brugger W, Hufert Ft: Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow. Blood 1995;86:4086-4090.
59. Schrier RD, Nelson JA, Oldstone MB: Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science 1985;230:1048-1051.
60. Kondo K, Kaneshima H, Mocarski ES: Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci USA 1994;91:11879-11883.
61. Kondo K, Xu J, Mocarski ES: Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci USA 1996;93:11137-11142.
62. Mandanas RA, Saez RA, Selby GB, Confer DL: Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: examination of a preemptive plan of ganciclovir therapy. Am J Hematol 1996;51:104-111.
63. Boström L, Ringdén O, Gratama JW, Jacobsen N, Prentice HG, Zwaan FE, Nilsson B: A role of herpes virus serology for the development of acute graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation. Bone Marrow Transplant 1990;5:321-326.
64. van den Berg AP, Klompmaker IJ, Haagsma EB, Peeters PM, Meerman L, Verwer R, The TH, Slooff MJ: Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection. Clin Transplant 1996;10:224-231.
65. Schrier RD, McCutchan JA, Venable JC, Nelson JA, Wiley CA: T-cell-induced expression of human immunodeficiency virus in macrophages. J Virol 1990;64:3280-3288.
66. Pope M, Betjes MG, Romani N, Hirmand H, Cameron PU, Hoffman L, Gezelter S, Schuler G, Steinman RM: Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 1994;78:389-398.
67. Michelson S: Mechanisms of immunosuppression by human cytomagalovirus; in Doerr HW (ed): CMV-Related Immunopathology. Basel, Karger 1998, vol 21.
68. Duncombe AS, Meager A, Prentice HG, Grundy JE, Heslop HE, Hoffbrand AV, Brenner MK: Gamma-interferon and tumor necrosis factor production after bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with cytomegalovirus. Blood 1990;76:1046-1053.
69. Haagmans BL, Stals FS, van der Meide PH, Bruggeman CA, Horzinek MC, Schijns VE: Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus. J Virol 1994;68:2297-2304.
70. Haagmans BL, van der Meide PH, Stals FS, van der Eertwegh AJ, Claassen E, Bruggeman CA, Horzinek MC, Schijns VE: Suppression of rat cytomegalovirus replication by antibodies against gamma interferon. J Virol 1994;68: 2305-2312.
71. Hengel H, Lucin P, Jonjic S, Ruppert T, Koszinowski UH: Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape. J Virol 1994;68:289-297.
72. Hengel H, Esslinger C, Pool J, Goulmy E, Koszinowski UH: Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J Gen Virol 1995;76:2987-2997.
73. Fennie EH, Lie Ys, Low Ma, Gribling P, Anderson KP: Reduced mortality in murine cytomegalovirus infected mice following prophylactic murine interferon-gamma treatment. Antiviral Res 1988;10:27-39.
74. Heise MT, Virgin HW 4th: The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J Virol 1995;69:904-909.
75. Pavic I, Polic B, Crnkovic I, Lucin P, Jonjic S, Koszinowski UH: Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection. J Gen Virol 1993;74:2215-2223.
76. Lucin P, Jonjic S, Messerle M, Polic B, Hengel H, Koszinowski UH: Lae phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J Gen Virol 1994;75:101-110.
77. Presti RM, Pollock JL, Dal Canto AJ, O'Guin AK, Virgin HW 4th: Interferon-γ regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessel. J Exp Med 1998;188:577-588.
78. Shall TJ, Mak JY, DiGregorio D, Neote K: Receptor/ligand interactions in the CC chemokine receptor family. Adv Exp Med Biol 1993; 351:29-37.
79. Beisser PS, Vink C, Van Dam JG, Grauls SJ, Vanherle SJ, Bruggeman CA: The R33 G protein coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection. J Virol 1998;72:2352-2363.
80. Michelson S: Human cytomegalovirus escape from immune dectection. Intervirology 1999; 42:301-307.
81. Cebulla CM, Miller DM, Sedmak DD: Viral inhibition of interferon signal transduction. Intervirology 1999;42:325-330.